Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,300,144
-$5,382,013 QoQ
Shares Held
49,586
-82.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 271 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Derivatives in ARQT
reported options exposure · as of Jun 30, 2026CallValue
$3,088,716
CallShares
117,800
PutValue
$385,434
PutShares
14,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. ARQT ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in ARQT
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $385,434 | 14,700 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $3,088,716 | 117,800 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $1,300,144 | 49,586 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,105,208 | 131,800 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $1,057,844 | 44,900 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $6,682,157 | 283,623 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,840,112 | 97,800 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $6,430,210 | 221,426 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $203,280 | 7,000 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $891,605 | 47,300 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $6,800,513 | 360,770 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $265,785 | 14,100 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $740,256 | 52,800 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $1,782,249 | 127,122 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,821,684 | 116,476 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $408,204 | 26,100 | Call | Defined | 2025-05-19 | |
| 2025-03-31 | $451,996 | 28,900 | Put | Defined | 2025-05-19 | |
| 2024-12-31 | $663,068 | 47,600 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,468,792 | 105,441 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $759,185 | 54,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $1,032,968 | 111,072 | Shares | Defined | 2024-11-15 | |
| 2024-09-30 | $585,900 | 63,000 | Call | Defined | 2024-11-15 | |
| 2024-06-30 | $1,395,976 | 150,105 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $2,116,140 | 213,536 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $518,740 | 160,601 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $653,262 | 123,025 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,456,440 | 152,827 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $288,805 | 26,255 | Shares | Defined | 2023-05-16 | |
| 2022-09-30 | $364,637 | 19,081 | Shares | Defined | 2022-11-15 | |
| 2022-03-31 | $277,305 | 14,398 | Shares | Defined | 2022-05-17 | |
| 2020-09-30 | $321,098 | 10,959 | Shares | Defined | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||